Medikit Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3921060004
JPY
2,831.00
-5 (-0.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
PHC Holdings Corp.
Japan Lifeline Co., Ltd.
Jins Holdings, Inc.
Mani, Inc.
Fukuda Denshi Co., Ltd.
Menicon Co., Ltd.
Medikit Co., Ltd.
JEOL Ltd.
Eiken Chemical Co., Ltd.
Hogy Medical Co., Ltd.
Takara Bio, Inc.

Why is Medikit Co., Ltd. ?

1
Poor Management Efficiency with a low ROE of 6.42%
  • The company has been able to generate a Return on Equity (avg) of 6.42% signifying low profitability per unit of shareholders funds
2
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 6.42%
  • Poor long term growth as Net Sales has grown by an annual rate of 4.20% and Operating profit at 3.58% over the last 5 years
  • The company has been able to generate a Return on Equity (avg) of 6.42% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 4.20% and Operating profit at 3.58% over the last 5 years
4
Negative results in Jun 26
  • INTEREST(HY) At JPY 3.86 MM has Grown at 102.89%
  • DEBT-EQUITY RATIO (HY) Highest at -46.04 %
  • CASH AND EQV(HY) Lowest at JPY 43,946.7 MM
5
With ROE of 6.79%, it has a very attractive valuation with a 0.98 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 11.00%, its profits have fallen by -0.1% ; the PEG ratio of the company is 1.2
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Medikit Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Medikit Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Medikit Co., Ltd.
11.02%
-0.12
16.08%
Japan Nikkei 225
57.85%
1.98
29.31%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
4.20%
EBIT Growth (5y)
3.58%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.51
Sales to Capital Employed (avg)
0.50
Tax Ratio
33.38%
Dividend Payout Ratio
48.46%
Pledged Shares
0
Institutional Holding
0.14%
ROCE (avg)
22.48%
ROE (avg)
6.42%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
0.98
EV to EBIT
5.08
EV to EBITDA
3.54
EV to Capital Employed
0.96
EV to Sales
0.97
PEG Ratio
1.15
Dividend Yield
NA
ROCE (Latest)
18.84%
ROE (Latest)
6.79%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -2.8% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 4.59 times

-12What is not working for the Company
INTEREST(HY)

At JPY 3.86 MM has Grown at 102.89%

DEBT-EQUITY RATIO (HY)

Highest at -46.04 %

CASH AND EQV(HY)

Lowest at JPY 43,946.7 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.01 times

Here's what is working for Medikit Co., Ltd.

Debtors Turnover Ratio
Highest at 4.59 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -2.8% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Medikit Co., Ltd.

Interest
At JPY 3.86 MM has Grown at 102.89%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Debt-Equity Ratio
Highest at -46.04 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv
Lowest at JPY 43,946.7 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio
Lowest at 3.01 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio